Latest: Q2 2026 · from the cash-flow statements filed with the SEC
Free cash flow−$2.1M in Q2 2026 · −$3.9M over twelve months
Operating cash flow−$2.0M
Capital spending−$32K
Free cash flow−$2.1M
Cash / net income-0.3×
Analysis
In Q2 2026, Selectis Health generated −$2.0M of operating cash flow and spent $32K on capital projects, leaving free cash flow of −$2.1M. That is $1.8M less than in Q2 2025 (−$241K).
Over the twelve months to Jun 30, 2026, operating cash flow was −$3.4M; the largest uses were other financing ($3.7M), operating cash flow ($3.4M), capital spending ($470K); besides operations, cash came from other investing ($14.1M); the cash balance rose by $6.6M.
Operating cash flow was −$2.0M against net income of $8.1M — -0.3× profit, less cash than reported earnings, worth checking against working capital. The largest differences: gains on disposals −$10.2M, payables −$1.7M, receivables +$702K.
Free cash flow
Operating cash flow less capital spending.Latest (Q2 2026): Operating cash flow −$2.0M, Capital spending $32K.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $18K; the largest uses were net borrowing ($2.6M) and operating cash flow ($2.4M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$7.7M
Debt$19.3M
Net debt$11.6M
Due within a year$17.8M
Cash runway24 months
Selectis Health is burning cash: its operations consume cash, a free cash flow of −$3.9M a year at the current rate against $7.7M of cash and investments: a runway of about 24 months; $17.8M of debt also comes due within a year, which would need refinancing or new money before any new financing.
Principal due in each year as disclosed in the annual report, against $7.7M of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Every quarter
Quarter
Operating cash flow
Capital spending
Net borrowing (+) / repaid (−)
Cash drawn (+) / kept (−)
Free cash flow
Q2 2026
−$2.0M
−$32K
—
−$6.5M
−$2.1M
Q1 2026
−$2.3M
−$377K
−$325K
$375K
−$2.7M
Q4 2025
$644K
−$57K
$251K
−$630K
$587K
Q3 2025
$280K
−$4K
−$227K
$108K
$276K
Q2 2025
−$77K
−$164K
—
$694K
−$241K
Q1 2025
$1.0M
−$219K
$50K
−$634K
$816K
Q4 2024
−$423K
−$10K
$550K
$431K
−$433K
Q3 2024
−$1.2M
$1K
—
$2.2M
−$1.2M
Selectis Health: income statement and cash flow
Selectis Health, Q2 2026: revenue $4.7M (-55% year over year), operating margin -44.5%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.